D-1016-2019 Class II Terminated
FDA drug recall D-1016-2019 was initiated by Advanced Pharma Inc. on Mar 13, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jan 14, 2020). Affected quantity: 2400 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2019
- Initiation Date
- Mar 13, 2019
- Termination Date
- Jan 14, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2400 syringes
Product description
HYDROmorphone HCl 1 mg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 1 mg/5 mL (0.2 mg per mL), Sterile single use syringe, NDC: 42852-289-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide
Code information
Lots: 12/03/18 4090 28967S Exp. 4/2/2019; 12/03/18 6221 28967S Exp. 4/2/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1016-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026